Results FY2021 (€/MLN)

1,237.7
REVENUES
543.1
ADJUSTED EBITDA
356.9
ADJUSTED NET PROFIT
300.7
FREE CASH FLOW

Stock price

Press Releases

03/17/2023 - 22:05
DiaSorin Simplexa COVID Flu assay received U.S. FDA 510(K) clearance

Presentations

Latest financial results

Investor Day

EVENTS

06/30/2023
Stifel - European Healthcare Summit (Bordeaux)